title: Valvular-CHADS-VASc as a safer alternative to CHADS-VASc score.
authors.affiliation: Department of Elderly Medicine, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK.
authors.forename: Victoria
authors.initials: V
authors.lastname: Chatzimavridou-Grigoriadou
authors.affiliation: Assembly of Epidemiology and Biostatistics, Hellenic Society for the Advancement of Biomedical Research, Southport, UK.
authors.forename: Prodromos
authors.initials: P
authors.lastname: Kanavidis
authors.affiliation: Department of Elderly Medicine, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK; Department of General Medicine, Southport District General Hospital, Southport and Ormskirk NHS Foundation Trust, Southport, UK. Electronic address: a.mathioudakis@nhs.net.
authors.forename: Alexander G
authors.initials: AG
authors.lastname: Mathioudakis
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D001291:Attitude of Health Personnel; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D058996:Quality Improvement; D012107:Research Design / Q000592:standards; D020379:Risk Adjustment / Q000379:methods*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D011795:Surveys and Questionnaires; D006113:United Kingdom
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: Anticoagulation; Atrial fibrillation; Human; Prevention; Risk stratification; Stroke